Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.
Surf Bio has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in April 2024.
Surf Bio's investors include Bill & Melinda Gates Foundation, Perceptive Advisors, Breakout Ventures.
Surf Bio is headquartered in Palo Alto, United States.
Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.
Surf Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Surf Bio — Funding & Investors." VCBacked, April 30, 2024, https://www.vcbacked.co/company/surf-bio. Accessed November 12, 2026.
VCBacked. (2024). Surf Bio — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/surf-bio
{{cite web |title=Surf Bio — Funding & Investors |url=https://www.vcbacked.co/company/surf-bio |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Surf Bio? Request a listing update